Jump to content

User:MdWikiBot/Diazepam

From Simple English Wikipedia, the free encyclopedia
MdWikiBot/Diazepam
Clinical data
Pronunciation/dˈæzɪpæm/
Trade namesValium, Vazepam, Valtoco, others
AHFS/Drugs.comMonograph
MedlinePlusa682047
License data
Pregnancy
category
  • AU: C
Dependence
liability
High[1]
Addiction
liability
Moderate[2][3]
Routes of
administration
By mouth, IM, IV, rectal, nasal spray[4]
Legal status
Legal status
Pharmacokinetic data
Bioavailability76% (64–97%) by mouth, 81% (62–98%) rectal[6]
MetabolismLiverCYP2B6 (minor route) to desmethyldiazepam, CYP2C19 (major route) to inactive metabolites, CYP3A4 (major route) to desmethyldiazepam
Elimination half-life(50 hours); 20–100 hours (36–200 hours for main active metabolite desmethyldiazepam)[7][5]
ExcretionKidney
Identifiers
  • 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
Chemical and physical data
FormulaC16H13ClN2O
Molar mass284.74 g·mol−1
3D model (JSmol)
  • CN1C2=C(C(C3=CC=CC=C3)=NCC1=O)C=C(Cl)C=C2
  • InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3 checkY
  • Key:AAOVKJBEBIDNHE-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Diazepam, first marketed as Valium, is a medicine of the benzodiazepine family that typically produces a calming effect.[9] It is commonly used to treat a range of conditions, including anxiety, seizures, alcohol withdrawal syndrome, benzodiazepine withdrawal syndrome, muscle spasms, trouble sleeping, and restless legs syndrome.[9] It may also be used to cause memory loss during certain medical procedures.[10][11] It can be taken by mouth, inserted into the rectum, injected into muscle, injected into a vein or used as a nasal spray.[4][11] When given into a vein, effects begin in one to five minutes and last up to an hour.[11] By mouth, effects begin after 15 to 60 minutes.[12]

Common side effects include sleepiness and trouble with coordination.[11][7] Serious side effects are rare.[9] They include suicide, decreased breathing, and an increased risk of seizures if used too frequently in those with epilepsy.[9][11][13] Occasionally, excitement or agitation may occur.[14][15] Long term use can result in tolerance, dependence, and withdrawal symptoms on dose reduction.[9] Abrupt stopping after long-term use can be potentially dangerous.[9] After stopping, cognitive problems may persist for six months or longer.[14] It is not recommended during pregnancy or breastfeeding.[11] Its mechanism of action is by increasing the effect of the neurotransmitter gamma-aminobutyric acid (GABA).[14]

Diazepam was patented in 1959 by Hoffmann-La Roche.[9][16][17] It has been one of the most frequently prescribed medications in the world since its launch in 1963.[9] In the United States it was the highest selling medication between 1968 and 1982, selling more than two billion tablets in 1978 alone.[9] In 2017, it was the 135th most commonly prescribed medication in the United States, with more than five million prescriptions.[18][19] In 1985 the patent ended, and there are now more than 500 brands available on the market.[9] It is on the World Health Organization's List of Essential Medicines as an alternative to lorazepam.[20] The wholesale cost in the developing world is about US$0.01 per dose as of 2015.[21] In the United States, it is about US$0.40 per dose.[11]

References

[change | change source]
  1. Edmunds, Marilyn; Mayhew, Maren (17 April 2013). Pharmacology for the Primary Care Provider (4th ed.). Mosby. p. 545. ISBN 9780323087902. Archived from the original on 1 August 2020. Retrieved 31 July 2020.
  2. Clinical Addiction Psychiatry. Cambridge University Press. 2010. p. 156. ISBN 9781139491693. Archived from the original on 2017-09-08.
  3. Ries, Richard K. (2009). Principles of addiction medicine (4 ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. p. 106. ISBN 9780781774772. Archived from the original on 2017-09-08.
  4. 4.0 4.1 "Valtoco- diazepam spray". DailyMed. 13 January 2020. Archived from the original on 1 August 2020. Retrieved 13 February 2020.
  5. 5.0 5.1 "Diazepam Tablets BP 10mg - Summary of Product Characteristics (SmPC)". (emc). 16 September 2019. Archived from the original on 25 July 2020. Retrieved 25 July 2020.
  6. Dhillon S, Oxley J, Richens A (March 1982). "Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients". British Journal of Clinical Pharmacology. 13 (3): 427–32. doi:10.1111/j.1365-2125.1982.tb01397.x. PMC 1402110. PMID 7059446.
  7. 7.0 7.1 "Valium- diazepam tablet". DailyMed. 8 November 2019. Archived from the original on 28 June 2019. Retrieved 30 December 2019.
  8. "Interpreting Urine Drug Tests (UDT)". Archived from the original on 25 October 2023. Retrieved 24 October 2023.
  9. 9.00 9.01 9.02 9.03 9.04 9.05 9.06 9.07 9.08 9.09 Calcaterra NE, Barrow JC (April 2014). "Classics in chemical neuroscience: diazepam (valium)". ACS Chemical Neuroscience. 5 (4): 253–60. doi:10.1021/cn5000056. PMC 3990949. PMID 24552479.
  10. "Diazepam". PubChem. National Institute of Health: National Library of Medicine. 2006. Archived from the original on 2015-06-30. Retrieved 2006-03-11.
  11. 11.0 11.1 11.2 11.3 11.4 11.5 11.6 "Diazepam". The American Society of Health-System Pharmacists. Archived from the original on 2015-06-30. Retrieved 2015-06-05.
  12. Dhaliwal JS, Saadabadi A (2019). "Diazepam". StatPearls. StatPearls Publishing. PMID 30725707. Archived from the original on 8 March 2021. Retrieved 2019-10-13.
  13. Dodds TJ (March 2017). "Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature". The Primary Care Companion for CNS Disorders. 19 (2). doi:10.4088/PCC.16r02037. PMID 28257172.
  14. 14.0 14.1 14.2 Riss J, Cloyd J, Gates J, Collins S (August 2008). "Benzodiazepines in epilepsy: pharmacology and pharmacokinetics". Acta Neurologica Scandinavica. 118 (2): 69–86. doi:10.1111/j.1600-0404.2008.01004.x. PMID 18384456.
  15. Perkin, Ronald M. (2008). Pediatric hospital medicine : textbook of inpatient management (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 862. ISBN 9780781770323. Archived from the original on 1 August 2020. Retrieved 31 July 2020.
  16. Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 535. ISBN 9783527607495. Archived from the original on 1 August 2020. Retrieved 31 July 2020.
  17. US patent 3371085, Leo Henryk Sternbach & Earl Reeder, "5-ARYL-3H-1,4-BENZODIAZEPIN-2(1H)-ONES", published 1968-02-27, issued 1968-02-27, assigned to Hoffmann La Roche AG 
  18. "The Top 300 of 2020". ClinCalc. Archived from the original on 12 February 2021. Retrieved 11 April 2020.
  19. "Diazepam - Drug Usage Statistics". ClinCalc. Archived from the original on 12 April 2020. Retrieved 11 April 2020.
  20. World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  21. "Diazepam". International Drug Price Indicator Guide. Archived from the original on 28 March 2017. Retrieved 2 December 2015.